Acquisition method (AMC)
0
FSC 6505 × NAPROXEN TABLETS
NAPROXEN TABLETS
6505-01-200-2474 FSC 6505
NSN 6505-01-200-2474 (also written 6505012002474; NIIN 01-200-2474) is a naproxen tablets in Federal Supply Class 6505, Drugs and Biologicals. 2 manufacturer part numbers from 2 suppliers are on record. It was last purchased in Oct 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
The codes on record do not say whether this item is competed or bought from a named source.
Suffix (AMSC)
0
Competition
—
AMC 0: not established: the part has not completed screening. AMSC 0 The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | MILLIGRAMS NAPROXEN ACTIVE INGREDIENT 500.000 |
| PRIMARY CONTAINER TYPE CQCT | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | TABLETS 100.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | NAPROXEN TABLETS USP 500 MG 100S |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| NDC53746-0190-01 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC |
| NDC76282-0342-01 | 6GFC4 | EXELAN PHARMACEUTICALS INC DIV EXELAN PHARMACEUTICALS |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Oct 7, 2026
Last purchased
4 · 4.0/yr
Purchase records
$91.71
Total demand
$3.69
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Sep 22, 2026 | SPE2DX25D9900/SPE2DP26F004R ↗ | DMS PHARMACEUTICAL GROUP INC | — | $48.90 |
| Sep 25, 2026 | SPE2DX25D9900/SPE2DP26F018R ↗ | DMS PHARMACEUTICAL GROUP INC | — | $24.45 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F023K ↗ | DMS PHARMACEUTICAL GROUP INC | — | $14.67 |
| Oct 7, 2026 | SPE2DX25D9822/SPE2D227F0006 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $3.69 |
Demand history
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Oct 2026
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
no award yet
no awards on record
Listed source EXELAN PHARMACEUTICALS INC DIV EXELAN PHARMACEUTICALS
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 4 of the last 4 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 10, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-10-08.
- Full methodology →
Cite this page
Citation
NSN Explorer. "NAPROXEN TABLETS." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-200-2474/. Data as of October 19, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-200-2474/